1ml vial of semaglutide Semaglutide: Injection Home Kit – NativeMed SEMAGLUTIDE PEPTIDE VIAL – UMBRELLA

SELECT Trial: The Evidence for CV Coverage The SELECT trial (published in NEJM, November 2023) demonstrated that Wegovy reduces cardiovascular events: [27] 20% reduction in major adverse cardiovascular events (MACE) Includes heart attacks, strokes, and cardiovascular death 17,604 participants followed for ~3.3 years All participants had established cardiovascular disease plus obesity/overweight Typical Plan Coverage Criteria for CV Indication Medicare plans that cover Wegovy for cardiovascular risk reduction typically require: Clinical Criteria Established cardiovascular disease (prior heart attack, stroke, or peripheral artery disease) BMI (body mass index) 27 kg/m No Type 2 diabetes (or T2D not adequately controlled) Concurrent lifestyle modifications (diet and exercise) Required Documentation Cardiology records documenting established CVD Current BMI (height and weight within last 30 days) Letter of Medical Necessity from cardiologist or primary care provider Documentation of lifestyle modification attempts ICD-10 Codes for CV vs

If you're currently taking a compounded version of semaglutide or tirzepatide, this change won't happen overnight

The manic-depressive spectrum Manic-Depressive Illness Oxford University Press: New York 1990

HCPCS code J3420 is used to report the injection of vitamin B-12 cyanocobalamin, up to 1000 mcg, administered by a non-oral route such as intramuscular or subcutaneous injection

Research shows it can protect neurons from beta-amyloid toxicity and support the continued health of cholinergic systems, thereby helping to slow memory loss and preserve executive function in older adults experiencing cognitive challenges

Understanding the timeline for side effects can help set expectations for those beginning treatment with Ozempic